Omega-3 Fatty Acids during Pregnancy in Indigenous Australian Women of the Gomeroi Gaaynggal Cohort
Nutrients · 2023
DOI: 10.3390/nu15081943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Natalie L Gray und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, University of Newcastle, Callaghan, NSW 2308, Australia. Hauptthemen laut MEDLINE: Premature Birth, Pre-Eclampsia, Fatty Acids, Omega-3. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Department of the Prime Minister and Cabinet, Hunter Medical Research Institute.
Abstract (Originalsprache)
Higher dietary intakes of Omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) have been linked to lower rates of preterm birth and preeclampsia. The aim of this analysis was to describe dietary intake and fractions of red blood cell (RBC) membrane LC-PUFAs during pregnancy in a cohort of Indigenous Australian women. Maternal dietary intake was assessed using two validated dietary assessment tools and quantified using the AUSNUT (Australian Food and Nutrient) 2011–2013 database. Analysis from a 3-month food frequency questionnaire indicated that 83% of this cohort met national n-3 LC-PUFA recommendations, with 59% meeting alpha-linolenic acid (ALA) recommendations. No nutritional supplements used by the women contained n-3 LC-PUFAs. Over 90% of women had no detectable level of ALA in their RBC membranes, and the median Omega-3 Index was 5.5%. This analysis appears to illustrate a decline in concentrations of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) across gestation in women who had preterm birth. However, there was no visible trend in LC-PUFA fractions in women who experienced hypertension during pregnancy. Further research is needed to better understand the link between dietary intake of n-3 LC-PUFA-rich foods and the role of fatty acids in preterm birth and preeclampsia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health Sciences, University of Newcastle, Callaghan, NSW 2308, Australia.
- School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
- Immune Health Program, Hunter Medical Research Institute, New Lambton, NSW 2305, Australia.
- Food and Nutrition Research Program, Hunter Medical Research Institute, New Lambton, NSW 2305, Australia.
- Department of Rural Health, University of Newcastle, Tamworth, NSW 2340, Australia.
- Mater Medical Research Institute, South Brisbane, QLD 4101, Australia.
ORCID-Profile: Isobel Stoodley, Lisa G Wood, Clare E Collins, Leanne J Brown, Kirsty G Pringle, Tracy L Schumacher
Förderung
- National Health and Medical Research Council
- Department of the Prime Minister and Cabinet
- Hunter Medical Research Institute
- University of Newcastle Australia
- Mater Foundation and Equity Trustees
- QCF-ANZ bank Fund
- QCF-Thomas George Swallow Trust
- The H J Hinchey Cht Tst
Zitieren
APA
Gray, N. L., Stoodley, I., Wood, L. G., Collins, C. E., Brown, L. J., Rae, K. M., Pringle, K. G., Schumacher, T. L., & The Gomeroi Gaaynggal Advisory Committee (2023). Omega-3 Fatty Acids during Pregnancy in Indigenous Australian Women of the Gomeroi Gaaynggal Cohort. Nutrients. https://doi.org/10.3390/nu15081943
Vancouver
Gray NL, Stoodley I, Wood LG, Collins CE, Brown LJ, Rae KM, et al. Omega-3 Fatty Acids during Pregnancy in Indigenous Australian Women of the Gomeroi Gaaynggal Cohort. Nutrients. 2023. doi:10.3390/nu15081943
BibTeX
@article{Gray2023,
author = {Gray, Natalie L and Stoodley, Isobel and Wood, Lisa G and Collins, Clare E and Brown, Leanne J and Rae, Kym M and Pringle, Kirsty G and Schumacher, Tracy L and The Gomeroi Gaaynggal Advisory Committee},
title = {Omega-3 Fatty Acids during Pregnancy in Indigenous Australian Women of the Gomeroi Gaaynggal Cohort},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15081943}
}
EUVIMED